Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132.
Saved in:
| Title: | Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132. |
|---|---|
| Authors: | Burge DJ; Resolve Therapeutics, Miami, Florida, USA., Werth VP; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Boackle SA; University of Colorado School of Medicine, Aurora, Colorado, USA., Posada J; Resolve Therapeutics, Miami, Florida, USA jp@resolvebio.com. |
| Source: | Lupus science & medicine [Lupus Sci Med] 2024 Feb 07; Vol. 11 (1). Date of Electronic Publication: 2024 Feb 07. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: BMJ Country of Publication: England NLM ID: 101633705 Publication Model: Electronic Cited Medium: Print ISSN: 2053-8790 (Print) Linking ISSN: 20538790 NLM ISO Abbreviation: Lupus Sci Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2053-8790 |
|---|---|
| DOI: | 10.1136/lupus-2023-001113 |
